See more cardiac data, detect patients’ risk earlier

OMRON Complete takes an ECG with a regular blood pressure check for comprehensive cardiac insight to help better inform diagnoses and treatment decisions for your patients.

Instant AFib detection helps reduce the risk of stroke

Atrial fibrillation (AFib) commonly occurs with hypertension, and is associated with a 5x greater risk of stroke.1 With effective treatment, the risk of stroke can be reduced2,3. However, up to 50% of AFib cases present with no subjective symptoms, making it unlikely to detect in an annual physical exam.4 To reduce patients’ risk of stroke, medical guidelines recommend daily blood pressure measurements and screening with a single-lead electrocardiogram (ECG).5

Read more about Atrial Fibrillation here

Introducing Complete

Diagnostic Value of Atrial Fibrillation by Built-in Electrocardiogram Technology in a Blood Pressure Monitor

Hypertension is a well known risk factor for stroke in patients with atrial fibrillation. A new device, Complete, combines blood pressure monitoring with ECG monitoring which can accurately differentiate sinus rhythm from atrial fibrillation during a blood pressure measurement.6
Read more

With OMRON Complete, you can take an ECG with a regular blood pressure check

  • Takes two critical measurements at once to help detect patients' risk of stroke earlier
  • Provides accurate results to aid diagnoses and effective treatment recommendations
  • Helps patients and their caregivers actively monitor the risk of a stroke at home


  • AFib is associated with a 5x greater risk of stroke and heart failure, so it’s important to detect and begin treatment early.
  • Unfortunately, AFib can show no symptoms and may not be present during doctor’s visits because the episodes come and go, which means it’s often left undiagnosed.
  • Given how serious AFib complications can be, it is important for those who may be at risk to routinely record electrocardiogram (ECG) measurements, according to current medical guidelines.
  • OMRON Complete is NOT intended for diagnosis of any cardiac conditions without a healthcare professional. Consult a healthcare professional prior to use.

1. Complications: atrial fibrillation. NHS. Reviewed April 24, 2018. Accessed November 2, 2020.
2. Gómez-Outes A, Lagunar-Ruíz J, Terleira-Fernández A, Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2016;68(23):2508-2521.
3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857-867.
4. Esato M, Chun Y, An Y, et al. Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry. Chest. 2017;152(6):1266-1275.
5. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;ehaa612. doi:10.10/93/eurheartj/ehaa612.
6. Senoo K., et al. Diagnostic Value of Atrial Fibrillation by Built-in Electrocardiogram Technology in a Blood Pressure Monitor. 2020. J-STAGE, 2(7): 345-350